Search

everythinglearnresearchcommunity

for

Search:↓

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

A new compound was effective for imaging prostate cancer in rats.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Triamcinolone acetonide is slightly more effective than betamethasone for hair regrowth in localized alopecia areata.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

Adding a second method to PROTACs could improve cancer treatment.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tigason improved hair growth in a boy with monilethrix without side effects.

A3B5 can reduce skin pigmentation and slow melanoma growth.